Search Results

Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid “You can try, try, try—and fail, fail, fail,” Eric says. Instead of chasing linear progress, Eric encourages young scientists to stay playful longer—embracing Eric and his team rejected the calcium route entirely. Eric is clear: real innovation requires real partnerships.

November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).

June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC

: Virion Display to Discover a Novel Ligand of the Orphan GPCR GPRC5B and its Role in Obesity About Eric Johansen "I will be a 6th year Ph.D student in the chemical biology interface program at Johns Hopkins Eric Johansen on the web Johns Hopkins University Dr.

Eric Trinquet discusses the science and story behind pH Sense, Revvity’s innovative GPCR internalization Eric Trinquet What does it take to design a breakthrough GPCR assay—from idea to industrial impact? Eric Trinquet shares the inside story behind the development of pH Sense, Revvity’s latest innovation decades at the intersection of fluorescence chemistry, functional assays, and product development, Eric Inside This Episode How Eric and his team reimagined rare earth complexes to develop pH-sensitive probes

Build Your GPCR Assay Workflow Meet the Team behind pHSense™ Eric TRINQUET Sr Director Life Sciences Reagents, Revvity Eric Trinquet is a recognized expert in the field of immunoassays and fluorescence Eric Trinquet, Director of Research and Development at Revvity. Related Articles How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs Discover Eric Trinquet. Dr.